Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Pharmaceutical Statistics
|
May 22, 2023
How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacy
Anika Großhennig, Nele Henrike Thomas, Werner Brannath, et al.
Journal of Dentistry
|
May 8, 2025
Systematic review and meta-analysis on marginal bone loss of dental implants placed in augmented or pristine bone sites: Findings from clinical long-term studies
Sonja Memenga-Nicksch, Felix Marschner, Nele Henrike Thomas, et al.
Pharmaceutical Statistics
|
February 17, 2026
A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial
Xiaofei Liu, Nele Henrike Thomas, Elina Asikanius, et al.
Journal of Clinical Medicine
|
January 21, 2023
Using a Further Planning MRI after Neoadjuvant Androgen Deprivation Therapy Significantly Reduces the Radiation Exposure of Organs at Risk in External Beam Radiotherapy of Prostate Cancer
Roland Merten, Mirko Fischer, Hans Christiansen, et al.
Trials
|
July 20, 2025
Comparison of telemedicine-assisted psychotherapy, exercise therapy, or a combination of both in patients with post-COVID-19 syndrome (TelPoCo): study protocol for a randomized controlled trial
Sebastian Beyer, Mariel Nöhre, Isabell Pink, et al.
Circulation. Heart Failure
|
May 28, 2026
DIGIT-HF: Results From the Win Ratio Analyses
Xiaofei Liu, Nele Henrike Thomas, Dominik Berliner, et al.
European Heart Journal
|
May 10, 2026
Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial
Udo Bavendiek, Nele Henrike Thomas, Lars S Maier, et al.
European Journal of Heart Failure
|
January 22, 2025
The DIGIT-HF trial: Key amendments of study design
Udo Bavendiek, Dominik Berliner, Nele Henrike Thomas, et al.
European Journal of Heart Failure
|
May 19, 2025
DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials
Udo Bavendiek, Nele Henrike Thomas, Dominik Berliner, et al.
The New England Journal of Medicine
|
August 29, 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Udo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Pharmaceutical Statistics
|
May 22, 2023
How to avoid concerns with the interpretation of two primary endpoints if significant superiority in one is sufficient for formal proof of efficacy
Anika Großhennig, Nele Henrike Thomas, Werner Brannath, et al.
Journal of Dentistry
|
May 8, 2025
Systematic review and meta-analysis on marginal bone loss of dental implants placed in augmented or pristine bone sites: Findings from clinical long-term studies
Sonja Memenga-Nicksch, Felix Marschner, Nele Henrike Thomas, et al.
Pharmaceutical Statistics
|
February 17, 2026
A Statistical Concept for Conditional Marketing Authorisation Based on the Intermediate and Final Outcomes of a Single Confirmatory Randomised Clinical Trial
Xiaofei Liu, Nele Henrike Thomas, Elina Asikanius, et al.
Journal of Clinical Medicine
|
January 21, 2023
Using a Further Planning MRI after Neoadjuvant Androgen Deprivation Therapy Significantly Reduces the Radiation Exposure of Organs at Risk in External Beam Radiotherapy of Prostate Cancer
Roland Merten, Mirko Fischer, Hans Christiansen, et al.
Trials
|
July 20, 2025
Comparison of telemedicine-assisted psychotherapy, exercise therapy, or a combination of both in patients with post-COVID-19 syndrome (TelPoCo): study protocol for a randomized controlled trial
Sebastian Beyer, Mariel Nöhre, Isabell Pink, et al.
Circulation. Heart Failure
|
May 28, 2026
DIGIT-HF: Results From the Win Ratio Analyses
Xiaofei Liu, Nele Henrike Thomas, Dominik Berliner, et al.
European Heart Journal
|
May 10, 2026
Digitoxin in heart failure with reduced ejection fraction according to atrial fibrillation status: the DIGIT-HF trial
Udo Bavendiek, Nele Henrike Thomas, Lars S Maier, et al.
European Journal of Heart Failure
|
January 22, 2025
The DIGIT-HF trial: Key amendments of study design
Udo Bavendiek, Dominik Berliner, Nele Henrike Thomas, et al.
European Journal of Heart Failure
|
May 19, 2025
DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure (DIGIT-HF): Baseline characteristics compared to recent randomized controlled heart failure trials
Udo Bavendiek, Nele Henrike Thomas, Dominik Berliner, et al.
The New England Journal of Medicine
|
August 29, 2025
Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction
Udo Bavendiek, Anika Großhennig, Johannes Schwab, et al.
Page
of 1